medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-6-36-40medalphabet-2005Research ArticleСтатьиСРК‑подобные синдромы в клинике внутренних болезней: современное состояние проблемыIBS‑like syndromes in clinic of internal diseases: current state of problemhttps://orcid.org/0000-0002-8488-9235ОсадчукА. М.OsadchukA. M.

Осадчук Алексей Михайлович, д.м.н., проф. кафедры гастроэнтерологии

eLibrary SPIN: 9455–3982, ID651113

Web of Science: Р-9213–2015

Scopus ID: 24576966600 

Москва

Osadchuk Alexey M.

Web of Science: Р-9213–2015

Scopus ID: 24576966600 

Moscow

a.m.osadchuk2020@mail.ruЛоранскаяИ. Д.LoranskayaI. D.

Лоранская Ирина Дмитриевна, д.м.н., проф., зав. кафедрой гастроэнтерологии

eLibrary SPIN: 1793–1080, ID: 370313

Scopus ID36164230100 

Москва

Loranskaya Irina D.

Scopus ID36164230100 

Moscow

gastromapo@yandex.ruhttps://orcid.org/0000-0003-0485-6802ОсадчукМ. А.OsadchukM. A.

Осадчук Михаил Алексеевич, д.м.н., проф., зав. кафедрой поликлинической терапии

eLibrary SPIN: 3108–0478

Web of Science; В-9896–2018

Scopus ID: 6701741609 

Москва

Osadchuk Mikhail A.

Web of Science; В-9896–2018

Scopus ID: 6701741609 

Moscow

osadchuk.mikhail@yandex.ruФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияRussian Medical Academy for Continuing Professional Education, First Moscow StateRussian FederationФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет)РоссияMedical University n.a. I.M. SechenovRussian Federation20210706202116Практическая гастроэнтерология (1)3640Copyright © Осадчук А.М., Лоранская И.Д., Осадчук М.А., 20212021Осадчук А.М., Лоранская И.Д., Осадчук М.А.Osadchuk A.M., Loranskaya I.D., Osadchuk M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2005

СРК-подобные синдромы являются одной из наиболее важных проблем в гастроэнтерологии. Клиническая картина, идентичная таковой при синдроме раздраженного кишечника, может ассоциироваться с воспалительными заболеваниями кишечника, колоректальным раком, целиакией, пищевой аллергией, лактазодефицитной энтеропатией, нецелиакийной чувствительностью, к глютену, и другими заболеваниями. В связи с этим синдром раздраженного кишечника является диагнозом исключения и всегда требует проведения сложной дифференциальной диагностики для установления истинной причины заболевания, проведения адекватной терапии и достижения стойкой ремиссии. Целью обзора явилось получение научного знания о СРК-подобных синдромах и выработка оптимальной тактики ведения данных больных. В обзоре продемонстрировано, что клинические проявления СРК во многом носят неспецифический характер из-за частого перехода одной формы заболевания в другую, что создает определенные трудности в постановке диагноза. Своевременная диагностика СРК-подобных синдромов, нередко наслаивающихся на уже имеющуюся патологию СРК, значительно улучшает результаты лечения пациентов с кишечной симптоматикой и обеспечивает длительное сохранение ремиссии заболевания.

IBS-like syndromes are one of the most important problems in gastroenterology. The clinical picture is identical to that of irritable bowel syndrome can be associated with inflammatory bowel disease, colorectal cancer, celiac disease, food allergy, lactase deficiency enteropathy, non-celiac sensitivity, gluten and other diseases. In this regard, irritable bowel syndrome is a diagnosis of exclusion and always requires a rather complex differential diagnosis to establish the true cause of the disease, conduct adequate therapy and achieve a stable remission. The purpose of the review was to obtain scientific knowledge about IBS-like syndromes and to develop optimal management tactics for these patients. The review demonstrates that the clinical manifestations of IBS are largely nonspecific due to the frequent transition of one form of the disease to another, which creates certain difficulties in making a diagnosis. Timely diagnosis of IBS-like syndromes, often superimposed on the already existing IBS pathology, significantly improves the results of treatment of patients with intestinal symptoms and ensures long-term preservation of remission of the disease.

СРК-подобные синдромыцелиакиялактазодефицитная энтеропатияIBS-like syndromesceliac diseaselactase deficiency enteropathyReferencesChey W.D. Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. Am J Gastroenterol. 2016; 111: 366–71. DOI: 10.1038/ajg.2016.12.Chey W.D. Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. Am J Gastroenterol. 2016; 111: 366–71. DOI: 10.1038/ajg.2016.12.Borghini R., Donato G., Alvaro D., Picarelli A. New insights in IBS-like disorders: Pandora's box has been opened; a review. Gastroenterol Hepatol Bed Bench. 2017 Spring; 10 (2): 79–89. https://doi.org/10.22037/ghfbb.v0i0.10113.Borghini R., Donato G., Alvaro D., Picarelli A. New insights in IBS-like disorders: Pandora's box has been opened; a review. Gastroenterol Hepatol Bed Bench. 2017 Spring; 10 (2): 79–89. https://doi.org/10.22037/ghfbb.v0i0.10113.De Giorgio R., Volta U., Gibson P.R. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut. 2016; 65: 169–78. DOI: 10.1136/gutjnl-2015–309757.De Giorgio R., Volta U., Gibson P.R. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut. 2016; 65: 169–78. DOI: 10.1136/gutjnl-2015–309757.Fritscher-Ravens A., Schuppan D., Ellrichmann M., Schoch S., Röcken C., Brasch J. et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014; 147: 1012–20. DOI: 10.1053/j.gastro.2014.07.046.Fritscher-Ravens A., Schuppan D., Ellrichmann M., Schoch S., Röcken C., Brasch J. et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014; 147: 1012–20. DOI: 10.1053/j.gastro.2014.07.046.Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007 Aug; 26 (4): 535–44. DOI: 10.1111/j.1365–2036.2007.03399.x.Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007 Aug; 26 (4): 535–44. DOI: 10.1111/j.1365–2036.2007.03399.x.Marshall J.K., Thabane M., Garg A.X., Clark W.F., Moayyedi P., Collins S.M., Walkerton Health Study Investigators Eight-year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010 May; 59 (5): 605–11. DOI: 10.1136/gut.2009.202234.Marshall J.K., Thabane M., Garg A.X., Clark W.F., Moayyedi P., Collins S.M., Walkerton Health Study Investigators Eight-year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010 May; 59 (5): 605–11. DOI: 10.1136/gut.2009.202234.Klem F., Wadhwa A., Prokop L.J., Sundt W.J., Farrugia G., Camilleri M. et al. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017 Apr; 152 (5): 1042–1054.e1. DOI: 10.1053/j.gastro.2016.12.039.Klem F., Wadhwa A., Prokop L.J., Sundt W.J., Farrugia G., Camilleri M. et al. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017 Apr; 152 (5): 1042–1054.e1. DOI: 10.1053/j.gastro.2016.12.039.Ferreira A. I., Garrido M., Castro-Poças F. Irritable Bowel Syndrome: News from an Old Disorder. GE Port J Gastroenterol. 2020 Jul; 27 (4): 255–268. DOI: 10.1159/000503757.Ferreira A. I., Garrido M., Castro-Poças F. Irritable Bowel Syndrome: News from an Old Disorder. GE Port J Gastroenterol. 2020 Jul; 27 (4): 255–268. DOI: 10.1159/000503757.Mearin F., Lacy B.E., Chang L., Chey W.D., Lembo A.J., Simren M., et al. Bowel Disorders. Gastroenterology. 2016 Feb; S0016–5085 (16): 00222–5. DOI: 10.1053/j.gastro.2016.02.031.Mearin F., Lacy B.E., Chang L., Chey W.D., Lembo A.J., Simren M., et al. Bowel Disorders. Gastroenterology. 2016 Feb; S0016–5085 (16): 00222–5. DOI: 10.1053/j.gastro.2016.02.031.Enck P., Aziz Q., Barbara G., Farmer A.D., Fukudo S., Mayer E.A., et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016 Mar; 2 (1): 16014. DOI: 10.1038/nrdp.2016.14.Enck P., Aziz Q., Barbara G., Farmer A.D., Fukudo S., Mayer E.A., et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016 Mar; 2 (1): 16014. DOI: 10.1038/nrdp.2016.14.Camilleri M., Lasch K., Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Oct; 303 (7): G775–85. DOI: 10.1152/ajpgi.00155.2012.Camilleri M., Lasch K., Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Oct; 303 (7): G775–85. DOI: 10.1152/ajpgi.00155.2012.Dothel G., Barbaro M. R., Boudin H., Vasina V., Cremon C., Gargano L., et al. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2015 May; 148 (5): 1002–1011.e4. DOI: 10.1053/j.gastro.2015.01.042.Dothel G., Barbaro M. R., Boudin H., Vasina V., Cremon C., Gargano L., et al. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2015 May; 148 (5): 1002–1011.e4. DOI: 10.1053/j.gastro.2015.01.042.Boeckxstaens G.E., Wouters M.M. Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome. Neurogastroenterol Motil. 2017 Jun; 29 (6): 29. DOI: 10.1111/nmo.13007.Boeckxstaens G.E., Wouters M.M. Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome. Neurogastroenterol Motil. 2017 Jun; 29 (6): 29. DOI: 10.1111/nmo.13007.Buhner S., Li Q., Vignali S., Barbara G., De Giorgio R., Stanghellini V., et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology. 2009 Oct; 137 (4): 1425–34. DOI: 10.1053/j.gastro.2009.07.005.Buhner S., Li Q., Vignali S., Barbara G., De Giorgio R., Stanghellini V., et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology. 2009 Oct; 137 (4): 1425–34. DOI: 10.1053/j.gastro.2009.07.005.Chey W.D., Kurlander J., Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015; 313: 949–58. DOI: 10.1001/jama.2015.0954.Chey W.D., Kurlander J., Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015; 313: 949–58. DOI: 10.1001/jama.2015.0954.Ford A.C., Moayyedi P., Lacy B.E., Lembo A.J., Saito Y.A., Schiller LR, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014; 109: 2–26. DOI: 10.1038/ajg.2014.187.Ford A.C., Moayyedi P., Lacy B.E., Lembo A.J., Saito Y.A., Schiller LR, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014; 109: 2–26. DOI: 10.1038/ajg.2014.187.Picarelli A., Borghini R., Di Tola M., Marino M., Urciuoli C., Isonne C., et al. Intestinal, Systemic, and Oral Gluten-related Alterations in Patients With Nonceliac Gluten Sensitivity. J Clin Gastroenterol. 2016; 50: 849–58. DOI: 10.1097/MCG.0000000000000515.Picarelli A., Borghini R., Di Tola M., Marino M., Urciuoli C., Isonne C., et al. Intestinal, Systemic, and Oral Gluten-related Alterations in Patients With Nonceliac Gluten Sensitivity. J Clin Gastroenterol. 2016; 50: 849–58. DOI: 10.1097/MCG.0000000000000515.Picarelli A., Borghini R., Isonne C., Di Tola M. Reactivity to dietary gluten: new insights into differential diagnosis among gluten related gastrointestinal disorders. Pol Arch Med Wewn. 2013; 123: 708–12. DOI: 10.20452/pamw.2019.Picarelli A., Borghini R., Isonne C., Di Tola M. Reactivity to dietary gluten: new insights into differential diagnosis among gluten related gastrointestinal disorders. Pol Arch Med Wewn. 2013; 123: 708–12. DOI: 10.20452/pamw.2019.Leffler D. A., Green P. H., Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015; 12: 561–71. DOI: 10.1038/nrgastro.2015.131.Leffler D. A., Green P. H., Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015; 12: 561–71. DOI: 10.1038/nrgastro.2015.131.Picarelli A., Borghini R., Donato G., Di Tola M., Boccabella C., Isonne C., et al. Weaknesses of histological analysis in celiac disease diagnosis: new possible scenarios. Scand J Gastroenterol. 2014; 49: 1318–24. DOI: 10.3109/00365521.2014.948052.Picarelli A., Borghini R., Donato G., Di Tola M., Boccabella C., Isonne C., et al. Weaknesses of histological analysis in celiac disease diagnosis: new possible scenarios. Scand J Gastroenterol. 2014; 49: 1318–24. DOI: 10.3109/00365521.2014.948052.Leffler D.A., Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010; 105: 2520–4. DOI: 10.1038/ajg.2010.276.Leffler D.A., Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010; 105: 2520–4. DOI: 10.1038/ajg.2010.276.Rashid M., Lee J. Serologic testing in celiac disease: Practical guide for clinicians. Can Fam Physician. 2016; 62: 38–43.Rashid M., Lee J. Serologic testing in celiac disease: Practical guide for clinicians. Can Fam Physician. 2016; 62: 38–43.Catassi C., Elli L., Bonaz B., Bouma G., Carroccio A., Castillejo G., et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria. Nutrients. 2015; 7: 4966–77. DOI: 10.3390/nu7064966.Catassi C., Elli L., Bonaz B., Bouma G., Carroccio A., Castillejo G., et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria. Nutrients. 2015; 7: 4966–77. DOI: 10.3390/nu7064966.Borghini R., Puzzono M., Rosato E., Di Tola M., Marino M., Greco F., et al. Nickel-Related Intestinal Mucositis in IBS-Like Patients: Laser Doppler Perfusion Imaging and Oral Mucosa Patch Test in Use. Biol Trace Elem Res. 2016; 173: 55–61. DOI: 10.1007/s12011–016–0650–2.Borghini R., Puzzono M., Rosato E., Di Tola M., Marino M., Greco F., et al. Nickel-Related Intestinal Mucositis in IBS-Like Patients: Laser Doppler Perfusion Imaging and Oral Mucosa Patch Test in Use. Biol Trace Elem Res. 2016; 173: 55–61. DOI: 10.1007/s12011–016–0650–2.Magge S., Lembo A. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (NY) 2012; 8: 739–45.Magge S., Lembo A. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (NY) 2012; 8: 739–45.Staudacher H.M., Lomer M.C., Anderson J.L., Barrett J.S., Muir J.G., Irving P.M., et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012; 142: 1510–8. DOI: 10.3945/jn.112.159285.Staudacher H.M., Lomer M.C., Anderson J.L., Barrett J.S., Muir J.G., Irving P.M., et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012; 142: 1510–8. DOI: 10.3945/jn.112.159285.Nanayakkara W.S., Skidmore P.M., O'Brien L., Wilkinson T.J., Gearry R.B. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016; 9: 131–42. DOI: 10.2147/CEG.S86798.Nanayakkara W.S., Skidmore P.M., O'Brien L., Wilkinson T.J., Gearry R.B. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016; 9: 131–42. DOI: 10.2147/CEG.S86798.Enattah N.S., Sahi T., Savilahti E., Terwilliger J.D., Peltonen L., Järvelä I. Identification of a variant associated with adult-type hypolactasia. Nat Genet. 2002; 30: 233–7. DOI: 10.1038/ng826.Enattah N.S., Sahi T., Savilahti E., Terwilliger J.D., Peltonen L., Järvelä I. Identification of a variant associated with adult-type hypolactasia. Nat Genet. 2002; 30: 233–7. DOI: 10.1038/ng826.Deng Y., Misselwitz B., Dai N., Fox M. Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients. 2015; 7: 8020–35. DOI: 10.3390/nu7095380.Deng Y., Misselwitz B., Dai N., Fox M. Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients. 2015; 7: 8020–35. DOI: 10.3390/nu7095380.Böhmer CJ, Tuynman HA. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur J Gastroenterol Hepatol. 2001; 13: 941–4. DOI: 10.1097/00042737–200108000–00011.Böhmer CJ, Tuynman HA. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur J Gastroenterol Hepatol. 2001; 13: 941–4. DOI: 10.1097/00042737–200108000–00011.Misselwitz B., Pohl D., Frühauf H., Fried M., Vavricka S.R., Fox M. Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United European Gastroenterol J. 2013; 1: 151–9. DOI: 10.1177/2050640613484463.Misselwitz B., Pohl D., Frühauf H., Fried M., Vavricka S.R., Fox M. Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United European Gastroenterol J. 2013; 1: 151–9. DOI: 10.1177/2050640613484463.Thompson JR. Is irritable bowel syndrome an infectious disease? World J Gastroenterol. 2016; 22: 1331–4. DOI: 10.3748/wjg.v22.i4.1331.Thompson JR. Is irritable bowel syndrome an infectious disease? World J Gastroenterol. 2016; 22: 1331–4. DOI: 10.3748/wjg.v22.i4.1331.Pimentel M. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2016; 43: 37–49. DOI: 10.1111/apt.13437.Pimentel M. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2016; 43: 37–49. DOI: 10.1111/apt.13437.Quigley E.M. Small intestinal bacterial overgrowth: what it is and what it is not. Curr Opin Gastroenterol. 2014; 30: 141–6. DOI: 10.1097/MOG.0000000000000040.Quigley E.M. Small intestinal bacterial overgrowth: what it is and what it is not. Curr Opin Gastroenterol. 2014; 30: 141–6. DOI: 10.1097/MOG.0000000000000040.Shimura S., Ishimura N., Mikami H., Okimoto E., Uno G., Tamagawa Y., et al. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J Neurogastroenterol Motil. 2016; 22: 60–8. https://doi.org/10.5056/jnm15116Shimura S., Ishimura N., Mikami H., Okimoto E., Uno G., Tamagawa Y., et al. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J Neurogastroenterol Motil. 2016; 22: 60–8. https://doi.org/10.5056/jnm15116Schuppan D., Pickert G., Ashfaq-Khan M., Zevallos V. Non-celiac wheat sensitivity: differential diagnosis, triggers and implications. Best Pract Res Clin Gastroenterol. 2015; 29: 469–76. DOI: 10.1016/j.bpg.2015.04.002.Schuppan D., Pickert G., Ashfaq-Khan M., Zevallos V. Non-celiac wheat sensitivity: differential diagnosis, triggers and implications. Best Pract Res Clin Gastroenterol. 2015; 29: 469–76. DOI: 10.1016/j.bpg.2015.04.002.Junker Y., Zeissig S., Kim S.J., Barisani D., Wieser H., Leffler D.A., et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012; 209: 2395–408. DOI: 10.1084/jem.20102660.Junker Y., Zeissig S., Kim S.J., Barisani D., Wieser H., Leffler D.A., et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012; 209: 2395–408. DOI: 10.1084/jem.20102660.Herfarth H.H., Martin C.F., Sandler R.S., Kappelman M.D., Long M.D. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2014; 20: 1194–7. DOI: 10.1097/MIB.0000000000000077.Herfarth H.H., Martin C.F., Sandler R.S., Kappelman M.D., Long M.D. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2014; 20: 1194–7. DOI: 10.1097/MIB.0000000000000077.Borghini R., Puzzono M., Rosato E., Di Tola M., Marino M., Greco F., et al. Nickel-Related Intestinal Mucositis in IBS-Like Patients: Laser Doppler Perfusion Imaging and Oral Mucosa Patch Test in Use. Biol Trace Elem Res. 2016; 173: 55–61. https://doi.org/10.1007/s12011-016-0650-2Borghini R., Puzzono M., Rosato E., Di Tola M., Marino M., Greco F., et al. Nickel-Related Intestinal Mucositis in IBS-Like Patients: Laser Doppler Perfusion Imaging and Oral Mucosa Patch Test in Use. Biol Trace Elem Res. 2016; 173: 55–61. https://doi.org/10.1007/s12011-016-0650-2Volta U., Bardella M. T., Calabrò A., Troncone R., Corazza G. R. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014; 12: 85. DOI: 10.1097/MIB.0000000000000077.Volta U., Bardella M. T., Calabrò A., Troncone R., Corazza G. R. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014; 12: 85. DOI: 10.1097/MIB.0000000000000077.Picarelli A., Di Tola M., Vallecoccia A., Libanori V., Magrelli M., Carlesimo M., et al. Oral mucosa patch test: a new tool to recognize and study the adverse effects of dietary nickel exposure. Biol Trace Elem Res. 2011; 139: 151–9. DOI: 10.1007/s12011–010–8652-y.Picarelli A., Di Tola M., Vallecoccia A., Libanori V., Magrelli M., Carlesimo M., et al. Oral mucosa patch test: a new tool to recognize and study the adverse effects of dietary nickel exposure. Biol Trace Elem Res. 2011; 139: 151–9. DOI: 10.1007/s12011–010–8652-y.Zirwas M.J., Molenda M.A. Dietary nickel as a cause of systemic contact dermatitis. J Clin Aesthet Dermatol. 2009; 2: 39–43.Zirwas M.J., Molenda M.A. Dietary nickel as a cause of systemic contact dermatitis. J Clin Aesthet Dermatol. 2009; 2: 39–43.Tallkvist J., Bowlus C. L., Lönnerdal B. Effect of iron treatment on nickel absorption and gene expression of the divalent metal transporter (DMT1) by human intestinal Caco-2 cells. Pharmacol Toxicol. 2003; 92: 121–4. DOI: 10.1034/j.1600-0773.2003.920303.x.Tallkvist J., Bowlus C. L., Lönnerdal B. Effect of iron treatment on nickel absorption and gene expression of the divalent metal transporter (DMT1) by human intestinal Caco-2 cells. Pharmacol Toxicol. 2003; 92: 121–4. DOI: 10.1034/j.1600-0773.2003.920303.x.Das K.K., Buchner V. Effect of nickel exposure on peripheral tissues: role of oxidative stress in toxicity and possible protection by ascorbic acid. Rev Environ Health. 2007; 22: 157–73. https://doi.org/10.1515/REVEH.2007.22.2.157Das K.K., Buchner V. Effect of nickel exposure on peripheral tissues: role of oxidative stress in toxicity and possible protection by ascorbic acid. Rev Environ Health. 2007; 22: 157–73. https://doi.org/10.1515/REVEH.2007.22.2.157

The authors declare that there are no conflicts of interest present.